Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=3
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=3
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject&page=3
PubPharm (197)
21
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3) : A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Reilhac, C.
|
Dubourg, J.
|
Thang, C.
| +3
Wird geladen...
22
Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2) : A 52-week, open-label, multicentre phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Dubourg, J.
|
Fouqueray, P.
|
Quinslot, D.
| +2
Wird geladen...
23
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes : Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Frías, J.
|
Maaske, J.
|
Suchower, L.
| +4
Wird geladen...
24
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes : A post hoc analysis of pooled data from four phase 3 randomized clinical trials
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Lund, S.
|
Sattar, N.
|
Salsali, A.
| +2
Wird geladen...
25
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Dejgaard, T.
|
von Scholten, B.
|
Christiansen, E.
| +6
ErratumIn: Diabetes Obes Metab. 2022 Nov;24(11):2280. - PMID 36004610
Wird geladen...
26
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device : Results of a phase 3, randomized, double-blind trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Bailey, T.
|
Willard, J.
|
Klaff, L.
| +3
Wird geladen...
27
Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes : A phase III, randomized, controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Yan, X.
|
Jiang, S.
|
Lou, Y.
| +1
Wird geladen...
28
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Weng, J.
|
Zeng, L.
|
Zhang, Y.
| +14
Wird geladen...
29
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Klein, T.
|
Tammen, H.
|
Mark, M.
| +4
Wird geladen...
30
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes : Design and baseline characteristics of the SoliMix randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
McCrimmon, R.
|
Al Sifri, S.
|
Emral, R.
| +11
ErratumIn: Diabetes Obes Metab. 2021 Nov;23(11):2600. - PMID 34463418
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Medienart
197
Aufsätze
197
E-Artikel
197
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
197
Clinical Trial, Phase III
195
Journal Article
190
Randomized Controlled Trial
162
Research Support, Non-U.S. Gov't
160
Hypoglycemic Agents
141
Glycated Hemoglobin A
132
Multicenter Study
127
Blood Glucose
110
type 2 diabetes
86
hemoglobin A1c protein, human
65
9100L32L2N
65
Metformin
44
2ZM8CX04RZ
44
Insulin Glargine
38
Comparative Study
33
Glucosides
33
glycaemic control
30
phase III study
27
62340-29-8
27
Benzhydryl Compounds
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
43
2020-
154
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
197
Englisch
Haven't found what you're looking for?
Wird geladen...